Quantification of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in glioma

[1] Wester HJ(1999)Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging J Nucl med off Publ Soc Nucl Med 40 205-12

[2] Herz M(2016)Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas Neuro-Oncologia 18 1199-1208

[3] Weber W(2006)EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues Eur J Nucl Med Mol Imaging 33 1374-1380

[4] Heiss P(2011)German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids Nuklearmedizin 50 167-173

[5] Senekowitsch-Schmidtke R(2017)Determination of an optimal pharmacokinetic model of J Nucl Med 58 1278-1284

[6] Schwaiger M(2014) F-FET for quantitative applications in rat brain tumors Neuro-Oncologia 16 434-440

[7] Albert NL(2009)Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors Phys Med Biol 54 5525-5539

[8] Weller M(2015)The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma IEEE Trans Med Imaging 34 2233-2247

[9] Suchorska B(2003)Direct parametric reconstruction using anatomical regularization for simultaneous PET/MRI data Eur J Nucl Med Mol Imaging 30 519-524

[10] Galldiks N(2016)Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine Neurosurgery 79 535-540

[1] Wester HJ(1999)Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging J Nucl med off Publ Soc Nucl Med 40 205-12

[2] Herz M(2016)Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas Neuro-Oncologia 18 1199-1208

[3] Weber W(2006)EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues Eur J Nucl Med Mol Imaging 33 1374-1380

[4] Heiss P(2011)German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids Nuklearmedizin 50 167-173

[5] Senekowitsch-Schmidtke R(2017)Determination of an optimal pharmacokinetic model of J Nucl Med 58 1278-1284

[6] Schwaiger M(2014) F-FET for quantitative applications in rat brain tumors Neuro-Oncologia 16 434-440

[7] Albert NL(2009)Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors Phys Med Biol 54 5525-5539

[8] Weller M(2015)The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma IEEE Trans Med Imaging 34 2233-2247

[9] Suchorska B(2003)Direct parametric reconstruction using anatomical regularization for simultaneous PET/MRI data Eur J Nucl Med Mol Imaging 30 519-524

[10] Galldiks N(2016)Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine Neurosurgery 79 535-540